BIOVEST INTERNATIONAL, INC.Royalty Agreement • February 6th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 6th, 2008 Company Industry JurisdictionReference is made to the Royalty Agreement dated as of October 31, 2006 (as amended, modified or supplemented from time to time, the “Royalty Agreement”), by and between Biovest International, Inc. (the “Company”) and Accentia Biopharmaceuticals, Inc (“Accentia”). Capitalized terms used herein that are not defined shall have the meaning given to them in the Royalty Agreement.
CONVERSION AGREEMENT BETWEEN BIOVEST INTERNATIONAL, INC. AND ACCENTIA BIOPHARMACEUTICALS, INC.Conversion Agreement • February 6th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 6th, 2008 Company Industry JurisdictionThis Conversion Agreement (this “Conversion Agreement”) effective as of February 5, 2008, by and between BIOVEST INTERNATIONAL, INC., a Delaware corporation (“BIOVEST”) and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, (“ACCENTIA”) (collectively the “Parties”).
AMENDMENT NO. 2 to OVERADVANCE SIDE-LETTEROveradvance Side-Letter • February 6th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 6th, 2008 Company Industry JurisdictionThis AMENDMENT NO. 2 to OVERADVANCE SIDE-LETTER (this “Amendment”), dated as of January 31, 2008, is entered into by and among Accentia Biopharmaceuticals, Inc., a Florida corporation (the “Parent”), Analytica International, Inc., a Florida corporation (“Analytica”), Teamm Pharmaceuticals, Inc., a Florida corporation (“Teamm” and, collectively with the Parent and Analytica, the “Companies” and, each a “Company”) and Laurus Master Fund, Ltd., a Cayman Islands company (the “Purchaser”), for the purpose of amending the terms of the Overadvance Side Letter dated as of August 29, 2007 by and among the Companies and the Purchaser (as amended by that certain Amendment No. 1 to Overadvance Side-Letter dated as of October 21, 2007 by and among the Companies and the Purchaser and as may be further amended, modified or supplemented from time to time, the “Overadvance Side-Letter”) issued in connection with the Amended and Restated Security Agreement, dated as of April 29, 2005, and amended and re
as of January 31, 2008 Accentia Biopharmaceuticals, Inc.Warrant Amendment • February 6th, 2008 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 6th, 2008 Company Industry Jurisdiction